MAPK9 and cancer: The same is true for MAPK9/JNK2 the phosphorylation status of which is controlling metastatic processes by promoting the switch of tumor cells from mesenchymal-epithelial transition to epithelial-mesenchymal transition (58) and its inactivation was identified as a carcinogenic factor in other types of cancer (59).